Clinical Trial Update: Real-Life Outcomes of TAF/FTC/BIC in HIV Patients in Colombia

View source ↗

Summary

A completed real-world study from Colombia evaluating the HIV regimen TAF/FTC/BIC in patients receiving routine care, reporting treatment outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• TAF/FTC/BIC (tenofovir alafenamide/emtricitabine/bictegravir)

Snippet

Sponsor: Servicios de Salud IPS Suramericana S.A.S | Conditions: HIV Treatment | Status: COMPLETED